62 related articles for article (PubMed ID: 14646218)
1. Immunological detection of proteolytically activated epidermal-type transglutaminase (TGase 3) using cleavage-site-specific antibody.
Hitomi K; Ikeda N; Maki M
Biosci Biotechnol Biochem; 2003 Nov; 67(11):2492-4. PubMed ID: 14646218
[TBL] [Abstract][Full Text] [Related]
2. A novel approach for the detection of proteolytically activated transglutaminase 1 in epidermis using cleavage site-directed antibodies.
Iizuka R; Chiba K; Imajoh-Ohmi S
J Invest Dermatol; 2003 Sep; 121(3):457-64. PubMed ID: 12925200
[TBL] [Abstract][Full Text] [Related]
3. Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies.
Hitomi K; Presland RB; Nakayama T; Fleckman P; Dale BA; Maki M
J Dermatol Sci; 2003 Aug; 32(2):95-103. PubMed ID: 12850301
[TBL] [Abstract][Full Text] [Related]
4. Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles.
Yamane A; Fukui M; Sugimura Y; Itoh M; Alea MP; Thomas V; El Alaoui S; Akiyama M; Hitomi K
FEBS J; 2010 Sep; 277(17):3564-74. PubMed ID: 20716179
[TBL] [Abstract][Full Text] [Related]
5. Chronic ultraviolet radiation modulates epidermal differentiation as it up-regulates transglutaminase 1 and its substrates.
Lee DS; Quan G; Choi JY; Kim SY; Lee SC
Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):45-52. PubMed ID: 15634223
[TBL] [Abstract][Full Text] [Related]
6. Type I keratinocyte transglutaminase: expression in human skin and psoriasis.
Schroeder WT; Thacher SM; Stewart-Galetka S; Annarella M; Chema D; Siciliano MJ; Davies PJ; Tang HY; Sowa BA; Duvic M
J Invest Dermatol; 1992 Jul; 99(1):27-34. PubMed ID: 1351505
[TBL] [Abstract][Full Text] [Related]
7. Biochemical, structural, and transglutaminase substrate properties of human loricrin, the major epidermal cornified cell envelope protein.
Candi E; Melino G; Mei G; Tarcsa E; Chung SI; Marekov LN; Steinert PM
J Biol Chem; 1995 Nov; 270(44):26382-90. PubMed ID: 7592852
[TBL] [Abstract][Full Text] [Related]
8. Characterization of recombinant mouse epidermal-type transglutaminase (TGase 3): regulation of its activity by proteolysis and guanine nucleotides.
Hitomi K; Kanehiro S; Ikura K; Maki M
J Biochem; 1999 Jun; 125(6):1048-54. PubMed ID: 10348906
[TBL] [Abstract][Full Text] [Related]
9. Analysis of epidermal-type transglutaminase (TGase 3) expression in mouse tissues and cell lines.
Hitomi K; Horio Y; Ikura K; Yamanishi K; Maki M
Int J Biochem Cell Biol; 2001 May; 33(5):491-8. PubMed ID: 11331204
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte transglutaminase expression varies in squamous cell carcinomas.
Duvic M; Nelson DC; Annarella M; Cho M; Esgleyes-Ribot T; Remenyik E; Ulmer R; Rapini RP; Sacks PG; Clayman GL
J Invest Dermatol; 1994 Apr; 102(4):462-9. PubMed ID: 7908683
[TBL] [Abstract][Full Text] [Related]
11. Highly active soluble processed forms of the transglutaminase 1 enzyme in epidermal keratinocytes.
Kim SY; Chung SI; Steinert PM
J Biol Chem; 1995 Jul; 270(30):18026-35. PubMed ID: 7629111
[TBL] [Abstract][Full Text] [Related]
12. Identification of preferred substrate sequences for transglutaminase 1--development of a novel peptide that can efficiently detect cross-linking enzyme activity in the skin.
Sugimura Y; Hosono M; Kitamura M; Tsuda T; Yamanishi K; Maki M; Hitomi K
FEBS J; 2008 Nov; 275(22):5667-77. PubMed ID: 18959752
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminases in skin epidermis.
Hitomi K
Eur J Dermatol; 2005; 15(5):313-9. PubMed ID: 16172037
[TBL] [Abstract][Full Text] [Related]
14. Analysis on transglutaminase 1 and its substrates using specific substrate peptide in cultured keratinocytes.
Yamane M; Sugimura K; Kawasaki H; Tatsukawa H; Hitomi K
Biochem Biophys Res Commun; 2016 Sep; 478(1):343-348. PubMed ID: 27416753
[TBL] [Abstract][Full Text] [Related]
15. Novel transglutaminase inhibitors reduce the cornified cell envelope formation.
Kim SY; Park WM; Jung SW; Lee J
Biochem Biophys Res Commun; 1997 Apr; 233(1):39-44. PubMed ID: 9144392
[TBL] [Abstract][Full Text] [Related]
16. Inactive zymogen and highly active proteolytically processed membrane-bound forms of the transglutaminase 1 enzyme in human epidermal keratinocytes.
Steinert PM; Chung SI; Kim SY
Biochem Biophys Res Commun; 1996 Apr; 221(1):101-6. PubMed ID: 8660317
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro.
Candi E; Oddi S; Terrinoni A; Paradisi A; Ranalli M; Finazzi-Agró A; Melino G
J Biol Chem; 2001 Sep; 276(37):35014-23. PubMed ID: 11443109
[TBL] [Abstract][Full Text] [Related]
18. Determination of type I transglutaminase in differentiating normal and neoplastic human keratinocytes by an in situ radioimmunoassay.
Moore KG; Donadio AC; Sartorelli AC
Biochem Biophys Res Commun; 1993 Apr; 192(2):381-5. PubMed ID: 8097910
[TBL] [Abstract][Full Text] [Related]
19. In situ detection of active transglutaminases for keratinocyte type (TGase 1) and tissue type (TGase 2) using fluorescence-labeled highly reactive substrate peptides.
Itoh M; Kawamoto T; Tatsukawa H; Kojima S; Yamanishi K; Hitomi K
J Histochem Cytochem; 2011 Feb; 59(2):180-7. PubMed ID: 20876521
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin-like skin protein: a new marker of keratinocyte differentiation.
Méhul B; Bernard D; Schmidt R
J Invest Dermatol; 2001 Jun; 116(6):905-9. PubMed ID: 11407979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
